Literature DB >> 10471510

Ocular albinism: evidence for a defect in an intracellular signal transduction system.

M V Schiaffino1, M d'Addio, A Alloni, C Baschirotto, C Valetti, K Cortese, C Puri, M T Bassi, C Colla, M De Luca, C Tacchetti, A Ballabio.   

Abstract

G protein-coupled receptors (GPCRs) participate in the most common signal transduction system at the plasma membrane. The wide distribution of heterotrimeric G proteins in the internal membranes suggests that a similar signalling mechanism might also be used at intracellular locations. We provide here structural evidence that the protein product of the ocular albinism type 1 gene (OA1), a pigment cell-specific integral membrane glycoprotein, represents a novel member of the GPCR superfamily and demonstrate that it binds heterotrimeric G proteins. Moreover, we show that OA1 is not found at the plasma membrane, being instead targeted to specialized intracellular organelles, the melanosomes. Our data suggest that OA1 represents the first example of an exclusively intracellular GPCR and support the hypothesis that GPCR-mediated signal transduction systems also operate at the internal membranes in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471510     DOI: 10.1038/12715

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  50 in total

1.  Structural insights into human GPCR protein OA1: a computational perspective.

Authors:  Anirban Ghosh; Uddhavesh Sonavane; Sai Krishna Andhirka; Gopala Krishna Aradhyam; Rajendra Joshi
Journal:  J Mol Model       Date:  2011-09-22       Impact factor: 1.810

Review 2.  Development of the retina and optic pathway.

Authors:  Benjamin E Reese
Journal:  Vision Res       Date:  2010-07-18       Impact factor: 1.886

3.  An unconventional dileucine-based motif and a novel cytosolic motif are required for the lysosomal and melanosomal targeting of OA1.

Authors:  Rosanna Piccirillo; Ilaria Palmisano; Giulio Innamorati; Paola Bagnato; Domenico Altimare; Maria Vittoria Schiaffino
Journal:  J Cell Sci       Date:  2006-04-18       Impact factor: 5.285

4.  Abnormal crossing of the optic fibres shown by evoked magnetic fields in patients with ocular albinism with a novel mutation in the OA1 gene.

Authors:  L Lauronen; R Jalkanen; J Huttunen; E Carlsson; S Tuupanen; S Lindh; H Forsius; E-M Sankila; T Alitalo
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

5.  The protein Ocular albinism 1 is the orphan GPCR GPR143 and mediates depressor and bradycardic responses to DOPA in the nucleus tractus solitarii.

Authors:  Y Hiroshima; H Miyamoto; F Nakamura; D Masukawa; T Yamamoto; H Muraoka; M Kamiya; N Yamashita; T Suzuki; S Matsuzaki; I Endo; Y Goshima
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

Review 6.  Chaperoning G protein-coupled receptors: from cell biology to therapeutics.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Endocr Rev       Date:  2014-03-24       Impact factor: 19.871

Review 7.  Signaling pathways in melanosome biogenesis and pathology.

Authors:  Maria Vittoria Schiaffino
Journal:  Int J Biochem Cell Biol       Date:  2010-04-08       Impact factor: 5.085

8.  Identification of a novel GPR143 mutation in X-linked ocular albinism with marked intrafamilial phenotypic variability.

Authors:  Jae-Ho Jung; Eun Hye Oh; Jin-Hong Shin; Hyang-Sook Kim; Seo Young Choi; Kwang-Dong Choi; Changwook Lee; Jae-Hwan Choi
Journal:  J Genet       Date:  2018-12       Impact factor: 1.166

9.  Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1.

Authors:  Christopher E Touloukian; Wolfgang W Leitner; Rhonda E Schnur; Paul F Robbins; Yong Li; Scott Southwood; Alessandro Sette; Steven A Rosenberg; Nicholas P Restifo
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

10.  The ocular albinism type 1 gene product, OA1, spans intracellular membranes 7 times.

Authors:  Michio Sone; Seth J Orlow
Journal:  Exp Eye Res       Date:  2007-08-29       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.